Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Metastatic Cancer
Related studies linked through entity extraction aliases.
A Study of CriPec® Docetaxel Given to Patients With Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Study on VEGF Vaccination in Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides
- Status
- COMPLETED
- Phase
- N/A
N-of-1 Trial: Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Next pErsonalized Cancer tX With mulTi-omics and Preclinical Model
- Status
- COMPLETED
- Phase
- N/A
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Improving End-of-life Care by Continuing Medical Education and Electronic Decision Making Support for General Practitioners
- Status
- WITHDRAWN
- Phase
- NA
PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1
- Status
- COMPLETED
- Phase
- PHASE2
Genetically-informed Therapies for Patients With Metastatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE4
Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Goals of Care Discussions for Hospitalized Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- N/A
BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies in Subjects With Advanced Malignancies
- Status
- COMPLETED
- Phase
- NA